ENDO PHARMACEUTICALS HOLDINGS INC.
 

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

     Date of Report (Date of Earliest Event Reported): February 5, 2004 (February 5, 2004)

ENDO PHARMACEUTICALS HOLDINGS INC.

(Exact name of registrant as specified in its charter)
         
DELAWARE   01-15989   13-4022871
 
 
(State or other jurisdiction of incorporation)   (Commission File Number)   (I.R.S. Employer Identification No.)
         
100 Painters Drive        
Chadds Ford, Pennsylvania       19317
 
(Address of principal executive offices)   (Zip Code)

(610) 558-9800

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

 

 

Item 7. Financial Statements and Exhibits.

(a)   Financial Statements of Business Acquired.

     Not applicable.

(b)   Pro Forma Financial Information.

     Not applicable.

(c)   Exhibits.
     
Exhibit Number   Description
 
99.1   Press Release of Endo Pharmaceuticals Holdings Inc. dated February 5, 2004, reporting the Registrant’s financial results of the fiscal year ended December 31, 2003

Item 12. Results of Operations and Financial Condition.

The following information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section.

On February 5, 2004, the Registrant issued an earnings release announcing its financial results for the fiscal year ended December 31, 2003. A copy of the earnings release is furnished as Exhibit 99.1 and is incorporated herein by reference.

 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

             
    ENDO PHARMACEUTICALS HOLDINGS INC. (Registrant)
             
    By:   /S/ CAROL A. AMMON
       
        Name:   Carol A. Ammon
        Title:   Chairman & Chief Executive Officer
             
Dated: February 5, 2004            

 

 

INDEX TO EXHIBITS

     
Exhibit No.   Description
 
99.1   Press Release of Endo Pharmaceuticals Holdings Inc. dated February 5, 2004, reporting the Registrant’s financial results of the fiscal year ended December 31, 2003